SRPT ▼ -13.6% - Sarepta Therapeutics, Inc. $SRPT - Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year Sarepta Therapeutics fell 13.6% today following its announcement of scholarship recipients for its Route 79 Duchenne scholarship program. The decline suggests investors may have anticipated clinical or commercial news rather than a philanthropic initiative, or the market reaction reflects broader sector pressures unrelated to the scholarship announcement itself. 08-SEP-2026 09:08 AM ET